²Ä 23 ´Á 2003-12-10

¬ã¨sµo®i
¥Íª«§Þ³N»PÃĪ«¬ã¨s²Õ§Ü¸z¯f¬r·sÃĬãµo¦¨ªG¡A¤wÀò­ã¨ú±o¬ü°ê±M§Q

¸z¯f¬r¬O¥Ñpiconaviridae¬ì¤¤ªñ70ºØ¤£¦P¦å²M«¬©Ò²Õ¦¨¡A¥D­n¥]¬A¤p¨à³Â·ô¯f¬r¡]poliovirus¡^¡B¬_ÂÄ©_¯f¬r¡]coxackievirus¡^A¡BB«¬¡B¥ì¬ì¯f¬r¡]echovirus¡^¥H¤Î¸z¯f¬r68-71«¬¡C¸z¯f¬rÄÝ©ó©u¸`©Êªº¬y¦æ¯e¯f¡A¦b¤H¤fº÷±K¡BÀô¹ÒÀã¼öªº¨È¬w°ê®a¡A¸g±`ÃzµoÄY­«ªº¬y¦æ·P¬V¡A¨Ò¦p°¨¨Ó¦è¨È¡B·s¥[©Y¡B¦L¥§¤Îµá«ß»«µ¥¡C1998¦~¥xÆW´¿Ãzµo«D±`ÄY­«ªº¸z¯f¬r¬y¦æ·P¬V¡A·í®É¦³¼Æ¤d¦W¨àµ£¦]¸z¯f¬r71«¬¦Ó¤Þµo¤â¨¬¤f¯g (hand-foot-mouth disease)¥H¤Îªw¯l©Ê«|®lª¢(herpangina)¡A¨ä¤¤¦³405¦Wªº­«¯g¨àµ£¥H¤Î78¦Wªº¦º¤`®×¨Ò¡A¨ä­«¯g·P¬Vªº¦º¤`²v¬°19.3%¡A¦]¦Ó³y¦¨°ê¤º¥Á²³ªº®£·W¡C¤µ¦~¸z¯f¬r¯g¦P¼Ë¤]ÄøÄø±ý°Ê¡Aªñ¤é¦b¦Á¤î¦a°Ï§óµo¥Í¬Y®aÂå°|Ãzµo·s¥Í¨à¶°Åé·P¬V¸z¯f¬r¡A³y¦¨¤@¦WÀ¦¨à¦º¤`¡A¤@¦W­«¯g¤Î¤Q¾l¦W¦í°|Æ[¹îªº¯S®í®×¨Ò¡A¨¬¨£¸z¯f¬rªº·P¬V«Â¤O¤£®e©¿µø¡Cª½¦Ü¥Ø«e¬°¤î¡A¥@¬É¤W¤´µM¨S¦³¥ô¦ó¤@­Ó°ê®a¥i¥H¶}µo¥X¹w¨¾©ÎªvÀø¸z¯f¬r·P¬Vªº·sÃĩά̭]¡A¦]¦¹¶}µo§Ü¸z¯f¬rÃĪ«¹ï»OÆW¦Ó¨¥¬O«D±`«æ­¢¦Ó¥B­«­nªº½ÒÃD¡C

°ê®a½Ã¥Í¬ã¨s°|¥Íª«§Þ³N»PÃĪ«¬ã¨s²Õªº¸z¯f¬r¬ã¨s¹Î¶¤¡A­P¤O©ó§Ü¸z¯f¬r·sÃĪº¬ã¨s¡C¸g¹L¤£Â_ªº§V¤O¡A²×©óµo²{¤@ºØ¥i¥H§í¨î¸z¯f¬r½Æ»sªº·s«¬¤Æ¦Xª«¡]Imidazolidinone compounds¡^¡A¸g¹L¦UºØ¥Íª«¬¡©Êªº´ú¸Õ¡AÃÒ©ú³oÃþ¤Æ¦Xª«¥i¥H¦³®Äªº§í¨î¸z¯f¬r¡A¨ã¦³¼ç¤Oµo®i¬°ªvÀø¸z¯f¬r·P¬VªºÃĪ«¡C¥»µo©ú¦b¤µ¦~¤Q¤@¤ëÀò¬ü°ê±M§Q¤Î°Ó¼Ð§½¼f¬d³q¹L¡Aµ¹¤©±M§QÅv¡C

¨ì¥Ø«e¬°¤î¡A³o­Ó§Ü¸z¯f¬r­pµeÁ`¦@¦X¦¨¶W¹L500­Ó¥ý¾ÉÃĪ«¡A¸g¹L§Ü¸z¯f¬r¬¡©Êªº¿z¿ï(»Pªø©°¤j¾Ç¬I«H¦p±Ð±Â¤Î¦¨¥\¤j¾Ç¾¤·ØÄ£±Ð±Â¦X§@)»PÃĪ«°Ê¤O¾Ç¤Î°Êª«¥NÁªº´ú¸Õ«á¡A¦¨¥\ªºµo²{¤@­Ó¨ã¦³¶}µo¼ç¤Oªº­Ô¿ïÃĪ«¡C¦¹­Ô¿ïÃĪ«¦b°Êª«¼Ò¦¡ªº¹êÅ礤¡A¹ï¨ü·P¬VªºICR·s¥Í¤p¹«¨ã¦³©úÅ㪺¹w¨¾¤ÎªvÀøªº®ÄªG¡A¥Ø«e¥¿·Ç³Æ¶i¤JÁ{§É«e¸ÕÅç¡C
¡m¤å:±çÀA³©/³¯§Ó»¨; Äá¼v: ¶À·R¯u; ¥k¤W¹Ï: ±M§Qµo©ú¤H¤§¤@: ³¯§Ó»¨³Õ¤h¡n

¾Ç³N¬¡°Ê
°ê¤º¬y¦æ¯f¾Ç¤§¦^ÅU»P®i±æ®y½Í·|¨t¦CºtÁ¿¤§¥|

°ê¤º¬y¦æ¯f¾Ç¤§¦^ÅU»P®i±æ®y½Í·|¨t¦CºtÁ¿¤§¥|
ºtÁ¿¥DÃD: ½ÆÂø¯e¯fªº°ò¦]ÃöÁp©Ê¬ã¨s (Genetic Association Studies on Complex Diseases: New Alternatives Using Case-only or Case- spouse/Offspring Designs)
¥DÁ¿¤H: §õ¤å©v³Õ¤h(MD, Ph.D.)
°ê¥ß¥xÆW¤j¾Ç¤½¦@½Ã¥Í¾Ç°|¬y¦æ¯f¾Ç¬ã¨s©Ò
µû½×¤H: ±ç½é¸q°Æ°|ªø(Ph.D.)
°ê®a½Ã¥Í¬ã¨s°|
®É¶¡¡G92¦~12¤ë19¤é (¬P´Á¤­) 15:30 - 17:10
ºtÁ¿¦aÂI¡G °ê¥ß¥xÆW¤j¾ÇÂå¾Ç°|104Á¿°ó
¥D¿ì³æ¦ì¡G°ê®a½Ã¥Í¬ã¨s°| »P ¤¤¥¡¬ã¨s°|
¡m¤å:¸U´º©É; Äá¼v:³¯ÄR¬î¡n

¾Ç³N¬¡°Ê
°ê®a½Ã¥Í¬ã¨s°|²Ä¥|©¡¯f¬r©Ê¨xª¢»P¨xÀù¬ã°Q·|

·|ij¡G °ê®a½Ã¥Í¬ã¨s°|²Ä¥|©¡¯f¬r©Ê¨xª¢»P¨xÀù¬ã°Q·|(4th NHRI Conference on Viral Hepatitis and Hepatocellular Carcinoma)
®É¶¡¡G93¦~2¤ë7~8¤é (¬P´Á¤»¡B¤é)
¦aÂI¡G§»ùÖ´÷±æ¾Ç²ß¤¤¤ß (http://www.aspirepark.com.tw)
¦a§}¡G®ç¶é¿¤Às¼æ¶m°ª­ì§ø´÷±æ¸ô428¸¹
³ø¦W¡G½Ð©ó12¤ë22¤é«e¦Ü¥»°|ºô§} ³ø¦W
ºô§}¡Ghttp://www.nhri.org.tw >> ¾Ç³N¬¡°Ê
¥D¿ì³æ¦ì¡G°ê®a½Ã¥Í¬ã¨s°|°|¥~¬ã¨s·~°È³B
¡m¤å:³¯·¶§g; Äá¼v:¶À·R¯u¡n

¼v­µ¸`¥Ø
³Á·í³ÒÂå®vºtÁ¿: ¥_¬üªº SARS ¸gÅç

¼v­µ¸`¥Ø¡G ºtÁ¿¬ö¿ý¤ù
ºtÁ¿ÃD¥Ø¡G ¥_¬üªºSARS¸gÅç
(Epidemilogy of SARS Transmission in the Healthcare Setting: The North American Experience)
ºtÁ¿ÀɮסG HTMLÀÉ®× / PowerPointÀÉ®×

¥DÁ¿¤H¡G Lawrance Clifford McDonald, M.D.
-¬ü°ê¸ô©ö´µºû¤j¾Ç§U±Ð±Â(University of Louisvile, Louisville, Kentucky)
¬ü°ê¯e¯fºÞ¨î§½ÂåÀø«~½è«P¶i²ÕÂå¥Î¬y¦æ¯f¾Ç®a
ºtÁ¿¤é´Á¡G 2003-11-13
»y¨¥¡G ­^»y
¥D¿ì³æ¦ì¡G°ê®a½Ã¥Í¬ã¨s°|Á{§É¬ã¨s²Õ
Æ[¬Ý¼v­µ¸`¥Ø»Ý­n Windows Media Player ½Ð«ö¦¹³B¤U¸ü
¡m¤å:§õ¯Â«ï; Äá¼v:³¯ÄR¬î¡n